These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7433883)

  • 1. [Prognostic factors in plasmocytoma (author's transl)].
    Klener P; Donner L; Sak P; Strnad Z
    Sb Lek; 1980 Oct; 82(10):331-6. PubMed ID: 7433883
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential diagnosis and therapy of plasmocytoma of the head and neck (author's transl)].
    Löbe LP; Katenkamp D
    Laryngol Rhinol Otol (Stuttg); 1982 Jul; 61(7):388-91. PubMed ID: 7109802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytologic classification in the diagnosis and prognostic evaluation of plasmocytoma].
    Sakalová A; Chabronová I; Bonisová H; Seichertová E
    Vnitr Lek; 1986 Aug; 32(8):729-38. PubMed ID: 3765410
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multiple myeloma (author's transl)].
    Nakatsuji T; Matsumoto N; Kaku K; Hiroshige Y; Oda S; Shinohara K; Yaga K; Fujii S; Miwa S; Kamei T; Nagasawa T; Tani S
    Rinsho Ketsueki; 1980 Mar; 21(3):347-55. PubMed ID: 7411874
    [No Abstract]   [Full Text] [Related]  

  • 5. [Both sides breast localisation of Kahler disease. Cytological and histological patterns (author's transl)].
    Mottot C; Bastien H; Guerrin J; Justrabo E; Knopf JF; Cayot F; Aupecle P
    Arch Anat Cytol Pathol; 1978; 26(2):93-7. PubMed ID: 747423
    [No Abstract]   [Full Text] [Related]  

  • 6. The prognosis of multiple myeloma.
    Jansen J; Huijgens PC; Van der Velde EA
    Neth J Med; 1980; 23(6):246-51. PubMed ID: 7464969
    [No Abstract]   [Full Text] [Related]  

  • 7. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
    Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors and markers of activity in multiple myeloma (results of the Cooperative Group for Diagnosis and Treatment of Multiple Myeloma)].
    Spicka I; Cieslar P; Procházka B; Jirsa M; Chrz M; Gregora E; Klener P
    Cas Lek Cesk; 2000 Apr; 139(7):208-12. PubMed ID: 10916207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [IgM myeloma (author's transl)].
    Imbert Y; Douard H; Guérin V; Coomans D; Gonday G; Leng B
    Sem Hop; 1982 Jun; 58(22):1389-91. PubMed ID: 6287601
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasmocytic immunocytoma with a course of 20.5 years and tumour duplicity (author's transl)].
    Dyrhon V; Dyrhonová V
    Cas Lek Cesk; 1980 Nov; 119(46):1257-9. PubMed ID: 7459951
    [No Abstract]   [Full Text] [Related]  

  • 11. Upper airways locations of plasmocytoma.
    Courtmans I; Pigeolet Y; Hedayat AH; Vilain J
    Acta Otorhinolaryngol Belg; 2000; 54(4):487-90. PubMed ID: 11205453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic indicators for the diagnosis of multiple myeloma.
    Greipp P;
    Oncology (Williston Park); 2004 May; 18(5):558-60. PubMed ID: 15209186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor.
    Vela-Ojeda J; García-Ruiz Esparza MA; Padilla-González Y; Sánchez-Cortes E; García-Chávez J; Montiel-Cervantes L; Reyes-Maldonado E; Majluf-Cruz A; Mayani H
    Ann Hematol; 2009 Jan; 88(1):59-66. PubMed ID: 18648809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory features of newly diagnosed multiple myeloma: a retrospective, single-centre analysis.
    Mai YJ; Qi PJ; Xu Y; Zou DH; Wang YF; Zhao YZ; Yang RC; Xiao ZJ; Qiu LG
    Chin Med J (Engl); 2007 Oct; 120(19):1727-9. PubMed ID: 17935680
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multiple myeloma and the anion gap (author's transl)].
    Pigrau Serrallach C; Bosch Gil JA; Durán JR; Pahissa Berga A; Tornos Solano J; Zuazu Nagore FJ
    Med Clin (Barc); 1981 Oct; 77(6):243-6. PubMed ID: 7321639
    [No Abstract]   [Full Text] [Related]  

  • 16. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
    Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
    Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal insufficiency in myelomatosis. Prognostic factors and survival].
    Gregersen H; Ibsen JS; Nielsen M
    Ugeskr Laeger; 1997 May; 159(22):3387-92. PubMed ID: 9199025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic imaging in patients with multiple myeloma: appearance at magnetic resonance imaging].
    Kusumoto S
    Rinsho Ketsueki; 1997 Apr; 38(4):285-8. PubMed ID: 9146052
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma.
    Hungria VT; Maiolino A; Martinez G; Colleoni GW; Coelho EO; Rocha L; Nunes R; Bittencourt R; Oliveira LC; Faria RM; Pasquini R; Magalhães SM; Souza CA; Pinto Neto JV; Barreto L; Andrade E; Portella Mdo S; Bolejack V; Durie BG;
    Haematologica; 2008 May; 93(5):791-2. PubMed ID: 18450738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.